acrolein has been researched along with Age-Related Memory Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Deng, H; Dong, X; Li, K; Wang, L; Wang, X; Wu, Y; Xu, Y; Zhao, Y | 1 |
| Chen, Y; Fu, Y; Qin, Z; Xu, Y; Yang, P; Zhang, L; Zhang, Z | 1 |
2 other study(ies) available for acrolein and Age-Related Memory Disorders
| Article | Year |
|---|---|
Trans-cinnamaldehyde improves neuroinflammation-mediated NMDA receptor dysfunction and memory deficits through blocking NF-κB pathway in presenilin1/2 conditional double knockout mice.
Topics: Acrolein; Alzheimer Disease; Animals; Female; Hippocampus; I-kappa B Proteins; Long-Term Potentiation; Male; Memory Disorders; Mice; Mice, Knockout; Microglia; N-Methylaspartate; Neuroprotective Agents; NF-kappa B; Presenilin-1; Presenilin-2; Receptors, N-Methyl-D-Aspartate; Signal Transduction | 2019 |
Trans-cinnamaldehyde improves memory impairment by blocking microglial activation through the destabilization of iNOS mRNA in mice challenged with lipopolysaccharide.
Topics: Acrolein; Animals; Cell Survival; Cells, Cultured; Cerebral Cortex; Disease Models, Animal; Enzyme Stability; Escherichia coli; Lipopolysaccharides; Male; MAP Kinase Signaling System; Memory Disorders; Mice, Inbred ICR; Microglia; Neuroprotective Agents; Nitric Oxide; Nitric Oxide Synthase Type II; Nootropic Agents; Random Allocation; Rats, Sprague-Dawley; RNA, Messenger | 2016 |